Thanks to the high density of international and local financial service providers, companies from other industries have access to a sophisticated liquid capital market and modern financial infrastructure. There is also a broad range of project financing and investment consulting services on offer. A variety of support is also provided for assessing risks, as well as for mergers and takeovers.
Companies planning an IPO receive access via the Swiss stock exchange (SIX) to investors with substantial capital within Switzerland and abroad. Switzerland, being an attractive trading center, is especially interesting for companies from the pharmaceutical, biotechnology, and medical technology industries. The Swiss stock exchange is the most important Life Sciences stock exchange in Europe. BX Swiss offers a cost-effective and issuer-friendly alternative trading platform for small and medium-sized companies.
In addition to banking, the insurance business is also one of Switzerland’s most important sectors. With their vast value added, the insurance companies make an above-average contribution to the country's economic performance.